News

US Rare Cancer Market FDA Approved Rare Cancer Drug Clinical Trials Insight
Kuick Research Report Gives Detailed Insight On Ongoing Rare Disease Drug Market And Highlights Ongoing Clinical TrialsDelhi, ...
US FDA Orphan Drug Rare Disease Market Clinical Trials Drug Sales Insight 2030
Kuick Research Report Gives Detailed Insight On More Than 1400 FDA Orphan Designated Drugs And Highlights More Than USD 190 ...
Targeted Oncology6d
THE001, Novel Sarcoma Treatment, Earns FDA Orphan Drug Designation
THE001, a thermosensitive doxorubicin liposome for soft tissue sarcomas, received FDA orphan drug designation, offering ...